LifeStance Health Group (NASDAQ:LFST) Stock Price Up 5%

LifeStance Health Group, Inc. (NASDAQ:LFST) shares were up 5% during trading on Thursday . The stock traded as high as $6.08 and last traded at $6.07. Approximately 1,254,748 shares traded hands during trading, a decline of 17% from the average daily volume of 1,513,311 shares. The stock had previously closed at $5.78.

Analyst Ratings Changes

Several research analysts recently weighed in on the company. Barclays dropped their target price on LifeStance Health Group from $8.00 to $6.00 and set an “underweight” rating on the stock in a research note on Friday, August 9th. UBS Group dropped their price target on LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating on the stock in a research note on Thursday, August 15th. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $8.25.

LifeStance Health Group Trading Up 2.7 %

The company has a 50 day simple moving average of $5.42 and a two-hundred day simple moving average of $6.06. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.18 and a current ratio of 1.18. The firm has a market cap of $2.36 billion, a PE ratio of -12.88 and a beta of 1.20.

LifeStance Health Group (NASDAQ:LFST) last issued its earnings results on Thursday, August 8th. The company reported ($0.06) EPS for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.01. The company had revenue of $312.30 million for the quarter, compared to the consensus estimate of $305.85 million. LifeStance Health Group had a negative net margin of 15.69% and a negative return on equity of 11.92%. LifeStance Health Group’s quarterly revenue was up 20.3% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.13) earnings per share. Analysts expect that LifeStance Health Group, Inc. will post -0.25 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Danish J. Qureshi sold 150,000 shares of the company’s stock in a transaction on Friday, June 14th. The stock was sold at an average price of $5.21, for a total value of $781,500.00. Following the transaction, the insider now owns 439,002 shares of the company’s stock, valued at approximately $2,287,200.42. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, insider Kevin Michael Mullins sold 85,093 shares of the business’s stock in a transaction that occurred on Tuesday, June 11th. The shares were sold at an average price of $5.53, for a total value of $470,564.29. Following the sale, the insider now directly owns 4,650,571 shares of the company’s stock, valued at approximately $25,717,657.63. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Danish J. Qureshi sold 150,000 shares of the stock in a transaction that occurred on Friday, June 14th. The stock was sold at an average price of $5.21, for a total transaction of $781,500.00. Following the transaction, the insider now directly owns 439,002 shares of the company’s stock, valued at approximately $2,287,200.42. The disclosure for this sale can be found here. 6.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. grew its stake in shares of LifeStance Health Group by 0.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 744,617 shares of the company’s stock valued at $5,830,000 after buying an additional 5,112 shares in the last quarter. Swiss National Bank grew its position in LifeStance Health Group by 25.4% in the 1st quarter. Swiss National Bank now owns 186,800 shares of the company’s stock valued at $1,153,000 after acquiring an additional 37,800 shares in the last quarter. Brown Advisory Inc. increased its stake in LifeStance Health Group by 25.9% during the fourth quarter. Brown Advisory Inc. now owns 5,158,980 shares of the company’s stock worth $40,395,000 after purchasing an additional 1,062,887 shares during the period. Principal Financial Group Inc. increased its stake in LifeStance Health Group by 2.8% during the fourth quarter. Principal Financial Group Inc. now owns 4,006,344 shares of the company’s stock worth $31,370,000 after purchasing an additional 110,457 shares during the period. Finally, Assetmark Inc. lifted its position in shares of LifeStance Health Group by 21.6% during the fourth quarter. Assetmark Inc. now owns 11,895 shares of the company’s stock worth $93,000 after purchasing an additional 2,114 shares in the last quarter. 85.50% of the stock is currently owned by institutional investors and hedge funds.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.